CA2668487A1 - Erythropoietine derivee des oiseaux - Google Patents

Erythropoietine derivee des oiseaux Download PDF

Info

Publication number
CA2668487A1
CA2668487A1 CA002668487A CA2668487A CA2668487A1 CA 2668487 A1 CA2668487 A1 CA 2668487A1 CA 002668487 A CA002668487 A CA 002668487A CA 2668487 A CA2668487 A CA 2668487A CA 2668487 A1 CA2668487 A1 CA 2668487A1
Authority
CA
Canada
Prior art keywords
epo
composition
isolated mixture
ifn
glycosylated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002668487A
Other languages
English (en)
Inventor
Robert D. Ivarie
Guodong Liu
Jeffrey C. Rapp
Julie A. Morris
Alex J. Harvey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Georgia Research Foundation Inc
Synageva Biopharma Corp
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2668487A1 publication Critical patent/CA2668487A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/505—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention concerne l'érythropoïétine obtenue à partir d'AEufs pondus par des oiseaux transgéniques ayant des motifs de glycosylation liée -N ou liée -O aviaires.
CA002668487A 2006-11-09 2007-10-10 Erythropoietine derivee des oiseaux Abandoned CA2668487A1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US85789606P 2006-11-09 2006-11-09
US60/857,896 2006-11-09
US87760106P 2006-12-28 2006-12-28
US60/877,601 2006-12-28
US91850407P 2007-03-16 2007-03-16
US60/918,504 2007-03-16
PCT/US2007/021643 WO2008057161A1 (fr) 2006-11-09 2007-10-10 Érythropoiétine dérivée des oiseaux

Publications (1)

Publication Number Publication Date
CA2668487A1 true CA2668487A1 (fr) 2008-05-15

Family

ID=39364811

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002668487A Abandoned CA2668487A1 (fr) 2006-11-09 2007-10-10 Erythropoietine derivee des oiseaux

Country Status (6)

Country Link
EP (1) EP2076530A4 (fr)
JP (1) JP2010509327A (fr)
KR (1) KR20090090328A (fr)
AU (1) AU2007318209A1 (fr)
CA (1) CA2668487A1 (fr)
WO (1) WO2008057161A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009088998A2 (fr) * 2008-01-07 2009-07-16 Synageva Biopharma Corp. Glycosylation chez l'oiseau
UA107678C2 (uk) * 2009-09-23 2015-02-10 ратіофарм ГмбХ Процес очищення рекомбінантного людського еритропоетину (епо), епо, очищений таким чином, та фармацевтична композиція, що містить його
US20140066379A1 (en) * 2012-08-30 2014-03-06 Body Organ Biomedical Corp. Recombinant vector, transgenic fish egg using the same and biomaterial using the same
JP6920280B2 (ja) * 2016-03-31 2021-08-18 株式会社カネカ 精製されたネコ由来エリスロポエチンの製造方法
JP7027347B2 (ja) * 2016-08-23 2022-03-01 アレクシオン ファーマシューティカルズ インコーポレイテッド 卵白から異種タンパク質を精製する方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040019923A1 (en) * 1997-10-16 2004-01-29 Ivarie Robert D. Exogenous proteins expressed in avians and their eggs
DK1023442T3 (da) * 1997-10-16 2011-03-14 Univ Georgia Transgenetiske fugle og fremstilling af proteiner
US7129390B2 (en) * 1997-10-16 2006-10-31 Avigenics, Inc Poultry Derived Glycosylated Interferon Alpha 2b
ATE339507T1 (de) * 1998-06-15 2006-10-15 Gtc Biotherapeutics Inc Erythropoietin-analog-menschliches serum-albumin fusionsprotein
EP1438401B1 (fr) * 2001-09-18 2011-06-15 Synageva BioPharma Corp. Production d'oiseaux transgeniques par injection cytoplasmique
US20090064351A1 (en) * 2005-03-30 2009-03-05 Kaneka Corporation Transgenic bird producing erythropoietin and method of constructing the same

Also Published As

Publication number Publication date
EP2076530A1 (fr) 2009-07-08
JP2010509327A (ja) 2010-03-25
EP2076530A4 (fr) 2010-04-07
WO2008057161A1 (fr) 2008-05-15
AU2007318209A1 (en) 2008-05-15
KR20090090328A (ko) 2009-08-25

Similar Documents

Publication Publication Date Title
US7511120B2 (en) Glycosylated G-CSF obtained from a transgenic chicken
US7534929B2 (en) Avians expressing heterologous protein
US8372956B2 (en) Antibodies produced in a transgenic avian egg white
US20140336362A1 (en) Avian Derived Antibodies
CA2668487A1 (fr) Erythropoietine derivee des oiseaux
EP1931698B1 (fr) Production rapide d'un virus de titre eleve
US8563803B2 (en) Method of making protein in an egg of a transgenic chicken
CN1980571A (zh) 禽类及禽蛋中表达的外源蛋白质
US20090074718A1 (en) Avian derived erythropoietin
US7812127B2 (en) Glycosylated human G-CSF
AU2007227723B2 (en) Glycosylated G-CSF
US20090105462A1 (en) Glycosylated erythropoietin
US7803362B2 (en) Glycosylated interferon alpha
CN101595125A (zh) 禽类衍生的红细胞生成素
CN101405299A (zh) 糖基化的g-csf

Legal Events

Date Code Title Description
FZDE Discontinued
FZDE Discontinued

Effective date: 20111011